Effect of mifepristone on endometrial matrix metalloproteinase expression and leukocyte abundance in new medroxyprogesterone acetate users

Contraception

Volumn 76, Issue 1, 2007, Pages 57-65

  Li, Aimin ^a   Felix, Juan C ^a   Yang, Wangrong ^a   Xiong, David W ^a   Minoo, Parviz ^a   Jain, John K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Breakthrough bleeding; Depot medroxyprogesterone acetate (DMPA); Leukocyte; Matrix metalloproteinase (MMP); Mifepristone

Indexed keywords

CD3 ANTIGEN; GELATINASE B; INTERSTITIAL COLLAGENASE; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; MIFEPRISTONE; PLACEBO; TRYPTASE;

ADD ON THERAPY; ADULT; ARTICLE; BREAKTHROUGH BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ENDOMETRIUM BIOPSY; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; MAST CELL; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TREATMENT DURATION;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, SYNTHETIC; DNA PRIMERS; DOUBLE-BLIND METHOD; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; MATRIX METALLOPROTEINASES; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; MIFEPRISTONE; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TREATMENT OUTCOME; UTERINE HEMORRHAGE;

EID: 34250685017     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.03.005     Document Type: Article

References (49)

1. Newton J.R., D'Arcangues C., and Hall P.E. A review of "once-a-month" combined injectable contraceptives. J Obstet Gynaecol 4 Suppl 1 (1994) S1-S34
2. Tyler E.T., Levin M., Elliot J., and Dolman H. Present status of injectable contraceptives: results of seven-year study. Fertil Steril 21 (1970) 469-481
3. Belsey E.M. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use. Contraception 38 (1988) 207-225
4. Glasier A.F., Wang H., Davie J.E., Kelly R.W., and Critchley H.O. Administration of an antiprogesterone up-regulates estrogen receptors in the endometrium of women using Norplant: a pilot study. Fertil Steril 77 (2002) 366-372
5. Cheng L., Zhu H., Wang A., Ren F., Chen J., and Glasier A. Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel. Hum Reprod 15 (2000) 1969-1972
6. Weisberg E., Hickey M., Palmer D., et al. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. Hum Reprod 21 (2006) 295-302
7. Jain J.K., Nicosia A.F., Nucatola D.L., Lu J.J., Kuo J., and Felix J.C. Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate. Steroids 68 (2003) 1115-1119
8. Cadepond F., Ulmann A., and Baulieu E.E. RU486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med 48 (1997) 129-156
9. Henriet P., Cornet P.B., Lemoine P., et al. Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs). Ann N Y Acad Sci 955 (2002) 119-138 [discussion 157--8, 396--406]
10. Marbaix E., Kokorine I., Moulin P., Donnez J., Eeckhout Y., and Courtoy P.J. Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc Natl Acad Sci U S A 93 (1996) 9120-9125
11. Marbaix E., Kokorine I., Henriet P., Donnez J., Courtoy P.J., and Eeckhout Y. The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation. Biochem J 305 Pt 3 (1995) 1027-1030
12. Salamonsen L.A., and Woolley D.E. Matrix metalloproteinases in normal menstruation. Hum Reprod 11 Suppl 2 (1996) 124-133
13. Vincent A.J., Malakooti N., Zhang J., Rogers P.A., Affandi B., and Salamonsen L.A. Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B). Hum Reprod 14 (1999) 807-815
14. Vincent A.J., and Salamonsen L.A. The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives. Hum Reprod 15 Suppl 3 (2000) 135-143
15. Galant C., Vekemans M., Lemoine P., et al. Temporal and spatial association of matrix metalloproteinases with focal endometrial breakdown and bleeding upon progestin-only contraception. J Clin Endocrinol Metab 85 (2000) 4827-4834
16. Marbaix E., Vekemans M., Galant C., et al. Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users. Hum Reprod 15 Suppl 3 (2000) 120-134
17. Skinner J.L., Riley S.C., Gebbie A.E., Glasier A.F., and Critchley H.O. Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel. Hum Reprod 14 (1999) 793-799
18. Kokorine I., Marbaix E., Henriet P., et al. Focal cellular origin and regulation of interstitial collagenase (matrix metalloproteinase-1) are related to menstrual breakdown in the human endometrium. J Cell Sci 109 Pt 8 (1996) 2151-2160
19. Finn C.A. Implantation, menstruation and inflammation. Biol Rev Camb Philos Soc 61 (1986) 313-328
20. Shi W., Mognetti B., Campana A., and Bischof P. Metalloproteinase secretion by endometrial leukocyte subsets. Am J Reprod Immunol 34 (1995) 299-310
21. Jeziorska M., Nagase H., Salamonsen L.A., and Woolley D.E. Immunolocalization of the matrix metalloproteinases gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle. J Reprod Fertil 107 (1996) 43-51
22. Salamonsen L.A., and Lathbury L.J. Endometrial leukocytes and menstruation. Hum Reprod Update 6 (2000) 16-27
23. Vincent A.J., Zhang J., Ostor A., et al. Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding?. Hum Reprod 17 (2000) 1189-1198
24. Zhang J., Nie G., Jian W., Woolley D.E., and Salamonsen L.A. Mast cell regulation of human endometrial matrix metalloproteinases: a mechanism underlying menstruation. Biol Reprod 59 (1998) 693-703
25. Vincent A.J., Zhang J., Ostor A., et al. Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives. Hum Reprod 15 (2000) 123-130
26. Jain J.K., Li A., Yang W., Minoo P., and Felix J.C. Effects of mifepristone on proliferation and apoptosis of human endometrium in new users of medroxyprogesterone acetate. Hum Reprod 21 (2006) 798-809
27. Noyes R.W., Hertig A.T., and Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 122 (1975) 262-263
28. Jain J.K., Li A., Minoo P., Nucatola D.L., and Felix J.C. The effect of nonoxynol-9 on human endometrium. Contraception 71 (2005) 137-142
29. Jain J.K., Li A., Nucatola D.L., Minoo P., and Felix J.C. Nonoxynol-9 induces apoptosis of endometrial explants by both caspase-dependent and -independent apoptotic pathways. Biol Reprod 73 (2005) 3882-3888
30. Li A., Felix J.C., Hao J., Minoo P., and Jain J.K. Menstrual-like breakdown and apoptosis in human endometrial explants. Hum Reprod 20 (2005) 1709-1719
31. Li A., Felix J.C., Minoo P., Amezcua C.A., and Jain J.K. Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells. Fertil Steril 84 (2005) 202-211
32. Rodgers W.H., Matrisian L.M., Giudice L.C., et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 94 (1994) 946-953
33. Hampton A.L., and Salamonsen L.A. Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation. J Endocrinol 141 (1994) R1--R3
34. Marbaix E., Kokorine I., Donnez J., Eeckhout Y., and Courtoy P.J. Regulation and restricted expression of interstitial collagenase suggest a pivotal role in the initiation of menstruation. Hum Reprod 11 Suppl 2 (1996) 134-143
35. Kokorine I., Nisolle M., Donnez J., Eeckhout Y., Courtoy P.J., and Marbaix E. Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions. Fertil Steril 68 (1997) 246-251
36. Freitas S., Meduri G., Le Nestour E., Bausero P., and Perrot-Applanat M. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biol Reprod 61 (1999) 1070-1082
37. Cornet P.B., Galant C., Eeckhout Y., Courtoy P.J., Marbaix E., and Henriet P. Regulation of matrix metalloproteinase-9/gelatinase B expression and activation by ovarian steroids and LEFTY-A/endometrial bleeding-associated factor in the human endometrium. J Clin Endocrinol Metab 90 (2005) 1001-1011
38. Galant C., Berliere M., Dubois D., et al. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding. Am J Pathol 165 (2004) 83-94
39. Lathbury L.J., and Salamonsen L.A. In-vitro studies of the potential role of neutrophils in the process of menstruation. Mol Hum Reprod 6 (2000) 899-906
40. Jeziorska M., Salamonsen L.A., and Woolley D.E. Mast cell and eosinophil distribution and activation in human endometrium throughout the menstrual cycle. Biol Reprod 53 (1995) 312-320
41. Salamonsen L.A., Zhang J., and Brasted M. Leukocyte networks and human endometrial remodelling. J Reprod Immunol 57 (2002) 95-108
42. Critchley H.O., Wang H., Jones R.L., et al. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery. Hum Reprod 13 (1998) 1218-1224
43. Jones R.L., and Critchley H.O. Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery. Hum Reprod 15 Suppl 3 (2000) 162-172
44. Milne S.A., Rakhyoot A., Drudy T.A., Brechin S., Riley S.C., and Critchley H.O. Co-localization of matrix metalloproteinase-1 and mast cell tryptase in the human uterus. Mol Hum Reprod 7 (2000) 559-565
45. Rudolph-Owen L.A., Slayden O.D., Matrisian L.M., and Brenner R.M. Matrix metalloproteinase expression in Macaca mulatta endometrium: evidence for zone-specific regulatory tissue gradients. Biol Reprod 59 (1998) 1349-1359
46. Schatz F., Papp C., Toth-Pal E., and Lockwood C.J. Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells. J Clin Endocrinol Metab 78 (1994) 1467-1472
47. Hampton A.L., Nie G., and Salamonsen L.A. Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects. Mol Hum Reprod 5 (1999) 365-371
48. Salamonsen L.A., Butt A.R., Hammond F.R., Garcia S., and Zhang J. Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab 82 (1997) 1409-1415
49. Cornet P.B., Picquet C., Lemoine P., et al. Regulation and function of LEFTY-A/EBAF in the human endometrium. mRNA expression during the menstrual cycle, control by progesterone, and effect on matrix metalloproteinases. J Biol Chem 277 (2002) 42496-42504